CIPLA

Latest stories

10h
The Hindu
HIV/AIDS: Pay now or pay forevercountries was not feasible. A year later, in 2001, in the absence of patent ba
HIV/AIDS: Pay now or pay forever
The Hindu / Posted 10 hours ago
countries was not feasible. A year later, in 2001, in the absence of patent barriers in India, Dr. Yusuf Hamied from Cipla proudly announced the availability of generic antiretroviral treatment for less than $1 per day. With this... Read more
20h
Business Standard India
Markets end in green on hopes of passing of GST billPaint 6.64 pc, PowerGrid 5.42%, Sun Pharma 5.33%, TCS 4.36%, Adaniports 3.32%,
Markets end in green on hopes of passing of GST bill
Business Standard India / Posted 20 hours ago
Paint 6.64 pc, PowerGrid 5.42%, Sun Pharma 5.33%, TCS 4.36%, Adaniports 3.32%, SBIN 2.51%, Lupin 2.47%, HindUnilever 2.06%, Cipla 1.99%, M&M 1.74%, Wipro 1.59%, Axis bank 1.58%, HDFC 1.38%, HDFC Bank 1.23% and ITC 1.16 per cent. However, Dr Reddy... Read more
18 related stories
1d
New Kerala
Profit booking suppresses equity markets ( - newkerala.com #97617Ports, up 2.95 per cent at Rs 231.95; Lupin, up 2.15 per cent at Rs 1,740.75; B
Profit booking suppresses equity markets ( - newkerala.com #97617
New Kerala / Posted yesterday
Ports, up 2.95 per cent at Rs 231.95; Lupin, up 2.15 per cent at Rs 1,740.75; Bajaj Auto, up 1.56 per cent at Rs 2,702; Cipla, up 1.47 per cent at Rs 528.15; and Hindustan Unilever (HUL), up 1.47 per cent at Rs 921.50. Major Sensex losers were:... Read more
18 related stories
1d
dna
Sensex cracks 157 pts as banks fall, BoJ disappointsL&T 1.20%, Asian Paints 1.09% and RIL 1.03%. However, Adani Ports rose 2.95% fo
Sensex cracks 157 pts as banks fall, BoJ disappoints
dna / Posted yesterday
L&T 1.20%, Asian Paints 1.09% and RIL 1.03%. However, Adani Ports rose 2.95% followed by Lupin 2.15%, Bajaj Auto 1.89%, Cipla 1.83%, HUL 1.47 %, Tata Steel 1.27%, M&M 1.01% and Sun Pharma 0.72%. Among the BSE sectoral indices, telecom fell by... Read more
18 related stories
1d
New Kerala
Indian markets slip on Friday - newkerala.com #97491Capital goods and banking stocks mostly took a hit on Friday. Top gainers on F
Indian markets slip on Friday - newkerala.com #97491
New Kerala / Posted yesterday
Capital goods and banking stocks mostly took a hit on Friday. Top gainers on Friday included Adani Ports, Lupin, Cipla, Tata Power, Bajaj Auto, HUL and ZEEL while ICICI Bank, HDFC, Bank of Baroda, LT, BHEL, Wipro and Bharti Airtel figured among the... Read more
1d
The Economic Times
DRL, Cipla, Aurobindo among others to buy products from Tevaof the divested products are: Mayne Pharma Group, Impax Laboratories, Dr Reddy'
DRL, Cipla, Aurobindo among others to buy products from Teva
The Economic Times / Posted yesterday
of the divested products are: Mayne Pharma Group, Impax Laboratories, Dr Reddy's Laboratories, Sagent Pharmaceuticals, Cipla, Zydus Worldwide DMCC, Mikah Pharma, Perrigo Pharma International, Aurobindo Pharma USA, Prasco and 3M Company," FTC... Read more
3 related stories
2d
dna
Making it mandatory for doctors to write generic: Governmentmade, if it have reduced the prices of 1000 odd medicines." Citing examples of
Making it mandatory for doctors to write generic: Government
dna / Posted 2 days ago
made, if it have reduced the prices of 1000 odd medicines." Citing examples of differential pricing, Aggarwal said, "Cipla makes one medicine by three names and has kept different price for each. Cipla sells its branded Cetrizine that we take... Read more
2 related stories
2d
Calcutta News
Israeli pharma giant Teva to divest 79 drugs in Allergen mergerover 11 companies which include Mayne Pharma Group, Impax Laboratories, Dr. Red
Israeli pharma giant Teva to divest 79 drugs in Allergen merger
Calcutta News / Posted 2 days ago
over 11 companies which include Mayne Pharma Group, Impax Laboratories, Dr. Reddy’s Laboratories, Sagent Pharmaceuticals, Cipla, Zydus Worldwide, Mikah Pharma, Perrigo Pharma International, Aurobindo Pharma, Prasco, and 3M. The generic drug... Read more
3 related stories
3d
Business Wire
Chase Pharmaceuticals Presents Phase 2 Results for CPC-201 at 2016 Alzheimer’s Association International Conferencefinancing led by New Rhein Healthcare Investors, LLC and including, among other
Chase Pharmaceuticals Presents Phase 2 Results for CPC-201 at 2016 Alzheimer’s Association International Conference
Business Wire / Posted 3 days ago
financing led by New Rhein Healthcare Investors, LLC and including, among others, Edmond de Rothschild Investment Partners, Cipla Ventures and Brain Trust Accelerator Fund. Forward Looking Statements This press release contains forward-looking... Read more
4d
Business Standard India
Sensex surges 200 points, Nifty tops 8,650; Maruti Suzuki up 3%Cements gained 3% after the company’s net profit rose 76.5% to Rs 399.51 crore
Sensex surges 200 points, Nifty tops 8,650; Maruti Suzuki up 3%
Business Standard India / Posted 4 days ago
Cements gained 3% after the company’s net profit rose 76.5% to Rs 399.51 crore on 2.44% growth in total income to Rs 2677.93 crore in Q2 June 2016 over Q2 June 2015. Other notable losers are Lupin, Sun Pharma, Coal India, Cipla and T... Read more
10 related stories
5d
Business Standard India
Sensex holds 28,100 amid choppy trades; Midcap, Smallcap outperformSun Pharmaceutical Industries (down 0.06%) and Strides Shasun (down 0.07%) edge
Sensex holds 28,100 amid choppy trades; Midcap, Smallcap outperform
Business Standard India / Posted 5 days ago
Sun Pharmaceutical Industries (down 0.06%) and Strides Shasun (down 0.07%) edged lower. Cadila Healthcare (up 1.44%), Cipla (up 0.92%) and GlaxoSmithkline Pharmaceuticals (up 0.18%) edged higher. Dr Reddy's Laboratories was down 0.23% at Rs... Read more
6 related stories
5d
The Economic Times
From HR issues to cultural integration, the reasons behind M&A failureshas a major talent erosion risk, a lot of the value can be eroded overnight," s
From HR issues to cultural integration, the reasons behind M&A failures
The Economic Times / Posted 5 days ago
has a major talent erosion risk, a lot of the value can be eroded overnight," said Prabir Jha, global chief people officer, Cipla. Such key people issues are getting aggravated in a highly competitive deal environment featuring truncated timelines,... Read more
5d
The Economic Times
From HR issues to cultural integration, the things behind M&A failureshas a major talent erosion risk, a lot of the value can be eroded overnight," s
From HR issues to cultural integration, the things behind M&A failures
The Economic Times / Posted 5 days ago
has a major talent erosion risk, a lot of the value can be eroded overnight," said Prabir Jha, global chief people officer, Cipla. Such key people issues are getting aggravated in a highly competitive deal environment featuring truncated timelines,... Read more
5d
dna
Sensex zooms 292 pts to regain 28,000, Nifty hits 15-mth highthat supported the rally included Asian Paint, ICICI Bank, ONGC, Sun Pharma, HD
Sensex zooms 292 pts to regain 28,000, Nifty hits 15-mth high
dna / Posted 5 days ago
that supported the rally included Asian Paint, ICICI Bank, ONGC, Sun Pharma, HDFC Ltd, TCS, M&M, HDFC Bank, Lupin Ltd, Cipla, Wipro, Bharti Airtel, L&T and Infosys. Axis Bank after initial hesitancy on disappointing earning numbers, ended 0.14%... Read more
6 related stories
5d
The Hindu
Sensex zooms to retain 28k, Nifty hits 15-month highthat supported the rally included Asian Paint, ICICI Bank, ONGC, Sun Pharma, HD
Sensex zooms to retain 28k, Nifty hits 15-month high
The Hindu / Posted 5 days ago
that supported the rally included Asian Paint, ICICI Bank, ONGC, Sun Pharma, HDFC Ltd, TCS, M&M, HDFC Bank, Lupin Ltd, Cipla, Wipro, Bharti Airtel, L&T and Infosys. Axis Bank after initial hesitancy on disappointing earning numbers, ended 0.14... Read more
6 related stories
5d
Business Standard India
Nifty ends at 52-week high on G20 growth focus, GST hopescrore for the quarter ended June 30, 2016 (Q1FY17), due to higher provisioning
Nifty ends at 52-week high on G20 growth focus, GST hopes
Business Standard India / Posted 5 days ago
crore for the quarter ended June 30, 2016 (Q1FY17), due to higher provisioning for bad loans. The Supreme Court has asked Cipla to deposit Rs 175.07 crore within a period of six weeks with regard to cases pertaining to overcharging of certain... Read more
10 related stories
5d
dna
Sensex zooms 284 points led by banking stocks; recaptures 28,000-mark, Nifty crosses 8,600who notched up solid gains include Maruti Suzuki, SBI, ICICI Bank, HDFC Ltd, Su
Sensex zooms 284 points led by banking stocks; recaptures 28,000-mark, Nifty crosses 8,600
dna / Posted 5 days ago
who notched up solid gains include Maruti Suzuki, SBI, ICICI Bank, HDFC Ltd, Sun Pharma, ONGC, Asian Paint, HDFC Bank and Cipla. Broader markets were also in better shape with small-cap and mid-cap indices adding up to 0.98%. Globally, Hong... Read more
6 related stories
5d
The Hindu
Sensex zooms 284 pts at mid-session to recapture 28,000-markwho notched up solid gains include Maruti Suzuki, SBI, ICICI Bank, HDFC Ltd, Su
Sensex zooms 284 pts at mid-session to recapture 28,000-mark
The Hindu / Posted 5 days ago
who notched up solid gains include Maruti Suzuki, SBI, ICICI Bank, HDFC Ltd, Sun Pharma, ONGC, Asian Paint, HDFC Bank and Cipla. Broader markets were also in better shape with small-cap and mid-cap indices adding up to 0.98 per cent. Globally,... Read more
6 related stories
6d
Business Standard India
Sensex up over 100 points; Nifty eyes 8,600crore for the quarter ended June 30, 2016 (Q1FY17), due to higher provisioning
Sensex up over 100 points; Nifty eyes 8,600
Business Standard India / Posted 6 days ago
crore for the quarter ended June 30, 2016 (Q1FY17), due to higher provisioning for bad loans. The Supreme Court has asked Cipla to deposit Rs 175.07 crore within a period of six weeks with regard to cases pertaining to overcharging of certain... Read more
10 related stories
8d
The Economic Times
Drug overcharging case: Supreme Court directs Cipla to pay Rs 175.07 croreIn a note to stock exchanges late on Friday, Cipla said the writ petitions file
Drug overcharging case: Supreme Court directs Cipla to pay Rs 175.07 crore
The Economic Times / Posted 8 days ago
In a note to stock exchanges late on Friday, Cipla said the writ petitions filed in the Bombay High Court that were pending before Supreme Court have been retransferred to the Bombay High Court for final hearing. The initial order for the deposits... Read more
3 related stories
8d
Business Standard India
Cipla told to deposit Rs 175 crore in drug overcharging caseThe case pertains to 2003 when Cipla received a demand notice from the National
Cipla told to deposit Rs 175 crore in drug overcharging case
Business Standard India / Posted 8 days ago
The case pertains to 2003 when Cipla received a demand notice from the National Pharmaceutical Pricing Authority for alleged overcharging of drugs covered under price cap The Supreme Court... Read more
3 related stories
8d
The Economic Times
Drug overcharging case: Supreme Court asks Cipla to deposit Rs 175 crorethe Bombay High Court that were pending before the Supreme Court have been re-t
Drug overcharging case: Supreme Court asks Cipla to deposit Rs 175 crore
The Economic Times / Posted 8 days ago
the Bombay High Court that were pending before the Supreme Court have been re-transfered to the former for final hearing, Cipla said citing an apex court order. In a regulatory filing, Cipla said the Supreme Court had directed the government to... Read more
3 related stories
8d
Business Standard India
Cipla told to deposit Rs 175 cr in drug overcharging caseThe case pertains to 2003 when Cipla received a demand notice from the National
Cipla told to deposit Rs 175 cr in drug overcharging case
Business Standard India / Posted 8 days ago
The case pertains to 2003 when Cipla received a demand notice from the National Pharmaceutical Pricing Authority for alleged overcharging of drugs covered under price cap The Supreme Court has... Read more
3 related stories
8d
The Hindu
Sensex ends 93 pts up on earnings lift, fund inflowsgainers were Tata Motors (3.21 pc), Power Grid (2.52 pc), HDFC (1.78 pc), L&T (
Sensex ends 93 pts up on earnings lift, fund inflows
The Hindu / Posted 8 days ago
gainers were Tata Motors (3.21 pc), Power Grid (2.52 pc), HDFC (1.78 pc), L&T (1.14 pc), NTPC (1.10 pc), GAIL (1.02 pc), Cipla (0.83 pc), Tata Steel (0.83 pc) and Lupin (0.80 pc). However, Bajaj Auto eased 1.60 per cent followed by SBI 0.95 per... Read more
9 related stories
8d
dna
Sensex ends 93 pts up on earnings lift, fund inflowshigher. Major gainers were Tata Motors (3.21%), Power Grid (2.52%), HDFC (1.78%
Sensex ends 93 pts up on earnings lift, fund inflows
dna / Posted 8 days ago
higher. Major gainers were Tata Motors (3.21%), Power Grid (2.52%), HDFC (1.78%), L&T (1.14%), NTPC (1.10%), GAIL (1.02%), Cipla (0.83%), Tata Steel (0.83%) and Lupin (0.80%). However, Bajaj Auto eased 1.60% followed by SBI 0.95%, Coal India 0.83%,... Read more
9 related stories
8d
New Kerala
Markets reported gains on Friday - newkerala.com #94121On Friday, Tata Motors, HDFC, LT, Cipla and Lupin were top gainers while Bajaj
Markets reported gains on Friday - newkerala.com #94121
New Kerala / Posted 8 days ago
On Friday, Tata Motors, HDFC, LT, Cipla and Lupin were top gainers while Bajaj Auto, SBI, HUL, Sun Pharma and Wipro ended as losers. Playing action video games may boost driving skills... Miranda Kerr just said `yes` to Snapchat co-founder Evan... Read more
3 related stories
9d
The Economic Times
Templeton, ICICI’s bet on Indian pharmaceuticals is paying offICICI Prudential Asset Management Co., India's top money manager, has been buyi
Templeton, ICICI’s bet on Indian pharmaceuticals is paying off
The Economic Times / Posted 9 days ago
ICICI Prudential Asset Management Co., India's top money manager, has been buying Sun Pharmaceutical Industries Ltd. and Cipla Ltd., betting that the Food and Drug Administration will begin to indicate that its criticisms have been addressed and... Read more
9d
The Economic Times
Corporate hotshots like Azim Premji, Narayana Murthy's family offices on the rise-- famously called 'family offices' -- manage family wealth that can match the
Corporate hotshots like Azim Premji, Narayana Murthy's family offices on the rise
The Economic Times / Posted 9 days ago
-- famously called 'family offices' -- manage family wealth that can match the assets of top companies such as Bajaj Auto, Cipla and Godrej Industries. The country is home to 90 mammoth single family offices (SFOs) that manage private wealth in... Read more
9d
Business Wire
Indian API Market Outlook 2022 - Patent Expiry of Blockbuster Drugs Drives the MarketCompetitive Landscape 10. Opportunities and Recommendations Companies Mention
Indian API Market Outlook 2022 - Patent Expiry of Blockbuster Drugs Drives the Market
Business Wire / Posted 9 days ago
Competitive Landscape 10. Opportunities and Recommendations Companies Mentioned - Aurobindo Pharma Limited - Biocon - Cipla Limited - Dr. Reddy's Laboratories - Glenmark Pharmaceuticals - Jubilant LifeSciences - Lupin Limited - Sun... Read more
9d
Business Standard India
Nifty Pharma index hits 2016 highsAurobindo Pharma, Cipla, Cadila and Sun Pharma from the Nifty Pharma index were
Nifty Pharma index hits 2016 highs
Business Standard India / Posted 9 days ago
Aurobindo Pharma, Cipla, Cadila and Sun Pharma from the Nifty Pharma index were up 1% each on the NSE. Shares of pharmaceuticals companies were in focus for the second straight day with the Nifty Pharma index... Read more
10d
Business Standard India
Markets pare early gains; IT shares weighin the American market. Sun Pharma was up 0.6%, Aurobindo Pharma gained 2% and
Markets pare early gains; IT shares weigh
Business Standard India / Posted 10 days ago
in the American market. Sun Pharma was up 0.6%, Aurobindo Pharma gained 2% and Glenmark Pharma was up 1%. Among others, Cipla and Lupin were up over 1% each. VRL Logistics was up 15% after the company in a release sais that the promoters have... Read more
10d
Business Standard India
Stocks climb second dayfinance, road builders and energy companies. Sun Pharmaceutical Industries Ltd
Stocks climb second day
Business Standard India / Posted 10 days ago
finance, road builders and energy companies. Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd. and Cipla Ltd., India's biggest drugmakers, were among the top performers on the Sensex. Wockhardt Ltd., a maker of generic... Read more
10d
Business Standard India
Nifty hits highest closing level in more than 11 monthsShasun (up 3.88%), IPCA Laboratories (up 3.23%), Divi's Laboratories (up 2.64%)
Nifty hits highest closing level in more than 11 months
Business Standard India / Posted 10 days ago
Shasun (up 3.88%), IPCA Laboratories (up 3.23%), Divi's Laboratories (up 2.64%), Dr Reddy's Laboratories (up 2.74%), Cipla (up 2.39%) and Lupin (up 1.37%) edged higher. GlaxoSmithKline Pharmaceuticals fell 0.5%. Glenmark Pharmaceuticals rose... Read more
10d
New Kerala
Value buying buoys equity markets - newkerala.com #93169India, up 3.23 per cent at Rs 329.25; Dr Reddy's Lab, up 2.74 per cent at Rs 3,
Value buying buoys equity markets - newkerala.com #93169
New Kerala / Posted 10 days ago
India, up 3.23 per cent at Rs 329.25; Dr Reddy's Lab, up 2.74 per cent at Rs 3,679.30; Gail, up 2.48 per cent at Rs 394.85; Cipla, up 2.39 per cent at Rs 517.80; and Sun Pharmaceuticals, up 1.89 per cent at Rs 797. Major Sensex losers were: Wipro,... Read more
35 related stories
10d
dna
Sensex advances 128 pts on second day led by pharmaceutical stocksof the 30-share Sensex pack finished higher. Major gainers included Coal India
Sensex advances 128 pts on second day led by pharmaceutical stocks
dna / Posted 10 days ago
of the 30-share Sensex pack finished higher. Major gainers included Coal India (3.23%), Dr Reddy's (2.74%), GAIL (2.48%), Cipla (2.39%), Hero MotoCorp (1.58%), Lupin (1.37%), HUL (1.31%), TCS (1.29%), ONGC (1.20%), HDFC Bank (1.15%) and ITC... Read more
2 related stories
11d
The Economic Times
Brexit leaves tech in a jam, but pharma’s not too badhas been the biggest gainer in the last month with the stock surging 16.73%. Ot
Brexit leaves tech in a jam, but pharma’s not too bad
The Economic Times / Posted 11 days ago
has been the biggest gainer in the last month with the stock surging 16.73%. Other pharma majors like Sun Pharma, Lupin, Cipla, Piramal and Cadila have all risen between 4% and 14%. According to Bloomberg estimates Sun Pharma is trading at 26.56... Read more
11d
The Economic Times
What did Fund Houses buy after Brexit voteof top four pharmaceutical companies fell in the range of 20-30% in the past on
What did Fund Houses buy after Brexit vote
The Economic Times / Posted 11 days ago
of top four pharmaceutical companies fell in the range of 20-30% in the past one year. Consequently, stocks such as Cipla, Sun Pharma and Lupin became attractive." Among BFSI companies, SBI has been a clear winner with top five fund houses... Read more
11d
Hindustantimes.com
No time for complacency, HIV infections went up in 74 countries over past decadecompanies played a huge role in boosting access to treatment by bringing down t
No time for complacency, HIV infections went up in 74 countries over past decade
Hindustantimes.com / Posted 11 days ago
companies played a huge role in boosting access to treatment by bringing down the price of HIV drugs. In 2001, Cipla introducing the world’s first 3-in-1 fixed dose ART combination (stavudine + lamivudine + nevirapine) at less than $1... Read more
116 related stories
12d
New Kerala
Indian benchmark indices decline on Monday - newkerala.com #92062in year-ago period and 4 percent in preceding quarter.. Other key losers inclu
Indian benchmark indices decline on Monday - newkerala.com #92062
New Kerala / Posted 12 days ago
in year-ago period and 4 percent in preceding quarter.. Other key losers included ICICI Bank, HDFC, SBI, Adani Ports, Cipla, Tata Steel, BHEL and GAIL. Infosys, reversed its Friday performance, and emerged among the gainers. Other top stocks... Read more
12d
New Kerala
Indian equity markets drop on global cues, profit booking - newkerala.com #92058Sensex losers were: ONGC, down 4.97 per cent at Rs 219; Bharti Airtel, down 3.9
Indian equity markets drop on global cues, profit booking - newkerala.com #92058
New Kerala / Posted 12 days ago
Sensex losers were: ONGC, down 4.97 per cent at Rs 219; Bharti Airtel, down 3.98 per cent at Rs 363.45; Hindustan Unilever, down 2.04 per cent at Rs 920.45; Tata Steel, down 1.94 per cent at Rs 365.60; and Cipla, down 1.56 per cent at R... Read more
68 related stories
12d
dna
Equities fall for a second straight session, Sensex washes out early gains, dips 90 ptsended lower while 10 ended higher. Major losers were, ONGC (4.97%), Bharti Airt
Equities fall for a second straight session, Sensex washes out early gains, dips 90 pts
dna / Posted 12 days ago
ended lower while 10 ended higher. Major losers were, ONGC (4.97%), Bharti Airtel (3.98%), HUL (2.04%), Tata Steel (1.94%), Cipla (1.56%), SBI (1.25%), GAIL (1.20%), HDFC (1.11%), Adani Ports (1.11%), RIL (0.82%), Dr Reddy's (0.78%) and Larsen... Read more
2 related stories
12d
Business Standard India
Sensex hovers around 28,000, Nifty aims 8,600; auto shares surgedown 0.48% ahead of the company's Q1 results today, 18 July 2016. Pharma stock
Sensex hovers around 28,000, Nifty aims 8,600; auto shares surge
Business Standard India / Posted 12 days ago
down 0.48% ahead of the company's Q1 results today, 18 July 2016. Pharma stocks were mixed. Aurobindo Pharma (down 0.79%), Cipla (down 0.60%), Wockhardt (down 0.27%), Cadila Healthcare (down 0.14%), Alkem Laboratories (down 0.12%) and... Read more
14d
New Kerala
Key Indian equity indices rally after previous flat week (Market Review) - newkerala.com #91255cent). The losers were led by Infosys (down 7.46 per cent), Wipro (1.31 per ce
Key Indian equity indices rally after previous flat week (Market Review) - newkerala.com #91255
New Kerala / Posted 14 days ago
cent). The losers were led by Infosys (down 7.46 per cent), Wipro (1.31 per cent), Sun Pharmaceuticals (1.05 per cent), Cipla (0.69 per cent) and PowerGrid (0.62 per cent). The week witnessed a sizeable influx of foreign funds. Provisional... Read more
68 related stories
16d
New Kerala
Indian equity markets close higher on positive global cues( - newkerala.com #90212losers were: ONGC, down 1.53 per cent at Rs 231; Infosys, down 1.45 per cent at
Indian equity markets close higher on positive global cues( - newkerala.com #90212
New Kerala / Posted 16 days ago
losers were: ONGC, down 1.53 per cent at Rs 231; Infosys, down 1.45 per cent at Rs 1,175.85; Mahindra and Mahindra, down 1.26 per cent at Rs 1,445.95; Sun Pharmaceuticals, down 1.05 per cent at Rs 770.15; and Cipla, down 0.84 per cent at Rs 5... Read more
68 related stories
18d
Business Standard India
Nifty tops 8,500 to end at highest close since August 2015the tender offer route at Rs 335 a piece. Pharma shares also witnessed profit
Nifty tops 8,500 to end at highest close since August 2015
Business Standard India / Posted 18 days ago
the tender offer route at Rs 335 a piece. Pharma shares also witnessed profit taking after recent gains. Sun Pharma, Cipla and Dr Reddy's Labs ended down 0.6%-1% each. Among other Sensex stocks, Tata Steel ended nearly 5% higher while Maruti... Read more
18d
Business Standard India
Markets come off day's high; Coal India dips 1%their first quarter earnings later this week. Pharma shares also witnessed pro
Markets come off day's high; Coal India dips 1%
Business Standard India / Posted 18 days ago
their first quarter earnings later this week. Pharma shares also witnessed profit taking after recent gains. Sun Pharma, Cipla and Dr Reddy's Labs were down over 1% each. Among key stocks, Quess Corp listed at Rs 500, a 58% premium against its... Read more
19d
The Economic Times
With several firms getting USFDA clearances, Street to breathe easy about pharma stocksGleevec; Lupin would have its first full quarter of Gavis acquisition as well a
With several firms getting USFDA clearances, Street to breathe easy about pharma stocks
The Economic Times / Posted 19 days ago
Gleevec; Lupin would have its first full quarter of Gavis acquisition as well as exclusivity sales of generic Glumetza. Cipla would also have consolidated its US acquisition Invagen. Price erosion and buyer consolidation has continued to... Read more
19d
FOX News
US pledges $410M to fight AIDS in South Africapharmaceutical firm last year to help cut the cost of HIV treatment. In Decembe
US pledges $410M to fight AIDS in South Africa
FOX News / Posted 19 days ago
pharmaceutical firm last year to help cut the cost of HIV treatment. In December 2014, South Africa chose four drug companies, including India's Cipla and local firm Aspen Pharmacare, to make and supply anti-retrovirals to pub... Read more
7 related stories
19d
Eye Witness News
US pledges $410 million to fight Aids in South Africastate-owned pharmaceutical firm last year to help cut the cost of HIV treatment
US pledges $410 million to fight Aids in South Africa
Eye Witness News / Posted 19 days ago
state-owned pharmaceutical firm last year to help cut the cost of HIV treatment. In December 2014, South Africa chose four drug companies, including India's Cipla and local firm Aspen Pharmacare, to make and supply Antiretroviral to public hospit... Read more
7 related stories
19d
AllAfrica.com
SA, India Sign Business PactsIndia's Tata Power for the production of Land Electronic Defence Systems (LEDS-
SA, India Sign Business Pacts
AllAfrica.com / Posted 19 days ago
India's Tata Power for the production of Land Electronic Defence Systems (LEDS-50), while a MoU was signed between India's CIPLA and the Dube Tradeport Corporation in Durban. This agreement is for the setting up of a bio-similar plant. The... Read more
6 related stories
More

People in this news